QCRH Stock Analysis: QCR Holdings | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 1.676m USD | 12M Return: 29.1% | US74727A1043 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 12.3M
EPS Trend: 91.3%
Qual. Beats: 5
Rev. Trend: 83.0%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
QCR Holdings, Inc. (NASDAQ: QCRH) is a multi-bank holding company headquartered in Moline, Illinois, that provides commercial and consumer banking as well as trust and asset management services. The company was incorporated in 1993 and operates within the regional banking segment of the financials sector.
Its deposit offerings include noninterest-bearing demand, interest-bearing demand, time, and brokered deposits. On the lending side, QCRH provides commercial and retail loans and leases, business lines of credit, term loans, commercial and residential real estate loans, and a range of consumer installment products such as motor vehicle, home improvement, home equity, and signature loans. The multi-bank holding structure is a common arrangement among U.S. regional banks, allowing the company to operate community-oriented banking subsidiaries under a single corporate umbrella while serving corporations, partnerships, individuals, and government agencies.
QCRH also issues trust preferred securities and offers investment services to its client base. As a small-cap regional bank with a market capitalization of approximately $1.6 billion, the company focuses primarily on relationship-based lending to small and mid-sized businesses and retail customers in its local markets.
- Net interest margin compresses as Fed cuts rates
- Commercial real estate loan losses pressure credit quality
- Loan growth accelerates across commercial and consumer segments
| Net Income: 141.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 5.73 > 1.0 |
| NWC/Revenue: -908.8% < 20% (prev 12.88%; Δ -921.7% < -1%) |
| CFO/TA 0.09 > 3% & CFO 841.9m > Net Income 141.7m |
| Net Debt (-596.9m) to EBITDA (167.8m): -3.56 < 3 |
| Current Ratio: 0.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (16.5m) vs 12m ago -2.75% < -2% |
| Gross Margin: 61.60% > 18% (prev 56.42%; Δ 5.18% > 0.5%) |
| Asset Turnover: 6.32% > 50% (prev 6.06%; Δ 0.26% > 0%) |
| Interest Coverage Ratio: 0.71 > 6 (EBIT TTM 155.0m / Interest Expense TTM 217.8m) |
| A: -0.57 (Total Current Assets 1.65b - Total Current Liabilities 7.21b) / Total Assets 9.80b |
| B: 0.09 (Retained Earnings 841.1m / Total Assets 9.80b) |
| C: 0.02 (EBIT TTM 155.0m / Avg Total Assets 9.68b) |
| D: 0.13 (Book Value of Equity 1.15b / Total Liabilities 8.64b) |
| Altman-Z'' = -3.20 = D |
| DSRI: 2.72 (Receivables 30.4m/10.6m, Revenue 611.7m/580.0m) |
| GMI: 0.92 (GM 56.42% / 61.60%) |
| AQI: 0.83 (AQ_t 0.81 / AQ_t-1 0.97) |
| SGI: 1.05 (Revenue 611.7m / 580.0m) |
| TATA: -0.07 (NI 141.7m - CFO 841.9m) / TA 9.80b) |
| Beneish M = -1.76 (Cap -4..+1) = CCC |
As of November 20, 2026, the stock is trading at USD 98.34 with a total of 89,813 shares traded. Over the past week, the price has changed by -4.85%, over one month by +0.88%, over three months by -2.62% and over the past year by +29.14%.
Current recommended Stop Loss: 91.20 (which is 7.3% or 2.8 ATR below the current price).
QCR Holdings has received a consensus analysts rating of 3.83. Therefore, it is recommended to buy QCRH.
- StrongBuy: 1
- Buy: 3
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 112.8 | 14.7% |
P/E Trailing = 12.2574
P/E Forward = 12.1951
P/S = 4.4474
P/B = 1.4725
P/EG = 1.0182
Revenue TTM = 611.7m USD
EBIT TTM = 155.0m USD
EBITDA TTM = 167.8m USD
Long Term Debt = 1.02b USD (from longTermDebt, last quarter)
Short Term Debt = 4.75m USD (from shortTermDebt, last quarter)
Debt = 1.02b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -596.9m USD (calculated: Debt 1.02b - CCE 1.62b)
Enterprise Value = 1.08b USD (1.68b + Debt 1.02b - CCE 1.62b)
Interest Coverage Ratio = 0.71 (Ebit TTM 155.0m / Interest Expense TTM 217.8m)
EV/FCF = 1.40x (Enterprise Value 1.08b / FCF TTM 772.9m)
FCF Yield = 71.64% (FCF TTM 772.9m / Enterprise Value 1.08b)
FCF Margin = 126.4% (FCF TTM 772.9m / Revenue TTM 611.7m)
Net Margin = 23.17% (Net Income TTM 141.7m / Revenue TTM 611.7m)
Gross Margin = 61.60% ((Revenue TTM 611.7m - Cost of Revenue TTM 234.9m) / Revenue TTM)
Gross Margin QoQ = 62.29% (prev 61.57%)
Tobins Q-Ratio = 0.11 (Enterprise Value 1.08b / Total Assets 9.80b)
Interest Expense / Debt = 21.32% (Interest Expense 217.8m / Debt 1.02b)
Taxrate = 7.94% (12.2m / 154.0m)
NOPAT = 142.7m (EBIT 155.0m * (1 - 7.94%))
Current Ratio = 0.23 (Total Current Assets 1.65b / Total Current Liabilities 7.21b)
Debt / Equity = 0.89 (Debt 1.02b / totalStockholderEquity, last quarter 1.15b)
Debt / EBITDA = -3.56 (Net Debt -596.9m / EBITDA 167.8m)
Debt / FCF = -0.77 (Net Debt -596.9m / FCF TTM 772.9m)
Total Stockholder Equity = 1.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.46% (Net Income 141.7m / Total Assets 9.80b)
RoE = 12.50% (Net Income TTM 141.7m / Total Stockholder Equity 1.13b)
RoCE = 7.21% (EBIT 155.0m / Capital Employed (Equity 1.13b + L.T.Debt 1.02b))
RoIC = 5.57% (NOPAT 142.7m / Invested Capital 2.56b)
WACC = 12.09% (E(1.68b)/V(2.70b) * Re(7.49%) + D(1.02b)/V(2.70b) * Rd(21.32%) * (1-Tc(0.08)))
Discount Rate = 7.49% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -86.01 | Cagr: -1.22%
[DCF] Terminal Value 66.87% ; FCFF base≈546.4m ; Y1≈626.4m ; Y5≈921.8m
[DCF] Fair Price = 547.9 (EV 8.33b - Net Debt -596.9m = Equity 8.93b / Shares 16.3m; r=12.09% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 91.31 | EPS CAGR: 9.40% | SUE: 1.03 | # QB: 5
Revenue Correlation: 82.99 | Revenue CAGR: 3.83% | SUE: 0.65 | # QB: 0
EPS current Quarter (2027-03-31): EPS=2.04 | Chg30d=+3.60% | Revisions=+38% | Analysts=6
EPS current Year (2026-12-31): EPS=8.70 | Chg30d=+2.47% | Revisions=+67% | GrowthEPS=+13.9% | GrowthRev=+1.0%
EPS next Year (2027-12-31): EPS=9.08 | Chg30d=+1.40% | Revisions=+29% | GrowthEPS=+4.4% | GrowthRev=+5.2%
[Analyst] Revisions Ratio: +61% (up=13, down=2)